Search

Elanco Animal Health Inc

Fechado

SetorSaúde

23.65 -0.04

Visão Geral

Variação de preço das ações

24h

Atual

Mín

23.05

Máximo

23.79

Indicadores-chave

By Trading Economics

Rendimento

-3M

54M

Vendas

-3M

1.4B

P/E

Médio do Setor

372.714

57.002

EPS

0.34

Margem de lucro

3.947

Funcionários

9,400

EBITDA

-42M

274M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+32.36% upside

Dividendos

By Acuity

Próximos Ganhos

4 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.7B

11B

Abertura anterior

23.69

Fecho anterior

23.65

Sentimento de Notícias

By Acuity

50%

50%

154 / 340 Ranking em Healthcare

Elanco Animal Health Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de ago. de 2026, 19:26 UTC

Elanco Animal Health shares are lower today, trading flat since Friday's close. The stock remains below its 20-day moving average with no specific news driving the decline.

14 de ago. de 2026, 23:36 UTC

Elanco Animal Health shares declined in after-market trading, remaining below the 20-day moving average amid concerns over a surprising drop in U.S. retail sales.

13 de ago. de 2026, 20:06 UTC

Elanco Animal Health Inc shares are higher today amid a broader market uptrend. The stock remains below its 20-day moving average.

12 de ago. de 2026, 19:51 UTC

Elanco Animal Health shares are declining today, despite high trading volume. No specific news was identified to explain the downward movement.

11 de ago. de 2026, 19:36 UTC

News

Elanco Animal Health receives FDA Emergency Use Authorization for CLiK Extra wound spray to combat New World screwworm infestations, boosting shares during Tuesday's session.

10 de ago. de 2026, 23:06 UTC

Elanco Animal Health shares are higher in after-market trading, following notable volatility during the session. The stock remains below its 20-day moving average.

7 de ago. de 2026, 23:36 UTC

Elanco Animal Health shares are higher in after-market trading, following a session spike despite no specific company news identified.

6 de ago. de 2026, 23:36 UTC

Elanco Animal Health Inc shares are higher in after-market hours. No specific news was identified to explain this movement, which shows routine trading.

5 de ago. de 2026, 19:52 UTC

News

Elanco Animal Health reported second-quarter revenue of $1.368 billion and raised its full-year adjusted EPS guidance to between $1.10 and $1.16. Shares are higher.

4 de ago. de 2026, 23:01 UTC

Elanco Animal Health Inc shares are higher in after-market hours, recovering from three days of declines amid broader market optimism and easing oil prices.

3 de ago. de 2026, 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 de jul. de 2026, 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 de jul. de 2026, 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 de jul. de 2026, 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 de jul. de 2026, 18:26 UTC

Correlated Moves
News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 de jul. de 2026, 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 de jul. de 2026, 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 de jul. de 2026, 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 de jul. de 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 de jul. de 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 de jul. de 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Comparação entre Pares

Variação de preço

Elanco Animal Health Inc Previsão

Preço-alvo

By TipRanks

32.36% parte superior

Previsão para 12 meses

Média 31.33 USD  32.36%

Máximo 34 USD

Mínimo 26 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para Elanco Animal Health Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

12 ratings

11

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

154 / 340 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat